Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms.

Jin H, Folsom D, Sasaki A, Mudaliar S, Henry R, Torres M, Golshan S, Glorioso DK, Jeste D.

Schizophr Res. 2011 Feb;125(2-3):295-9. doi: 10.1016/j.schres.2010.10.029.

2.

Successful aging in older adults with schizophrenia: prevalence and associated factors.

Ibrahim F, Cohen CI, Ramirez PM.

Am J Geriatr Psychiatry. 2010 Oct;18(10):879-86. doi: 10.1097/JGP.0b013e3181d57441.

3.

Successful cognitive and emotional aging.

Jeste DV, Depp CA, Vahia IV.

World Psychiatry. 2010 Jun;9(2):78-84.

4.

Perspectives on schizophrenia over the lifespan: a qualitative study.

Shepherd S, Depp CA, Harris G, Halpain M, Palinkas LA, Jeste DV.

Schizophr Bull. 2012 Mar;38(2):295-303. doi: 10.1093/schbul/sbq075.

5.

A snapshot of the age distribution of psychological well-being in the United States.

Stone AA, Schwartz JE, Broderick JE, Deaton A.

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):9985-90. doi: 10.1073/pnas.1003744107.

6.

Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.

Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS.

Arch Gen Psychiatry. 2010 Jul;67(7):674-82. doi: 10.1001/archgenpsychiatry.2010.63.

7.

What do we know about neuropsychological aspects of schizophrenia?

Palmer BW, Dawes SE, Heaton RK.

Neuropsychol Rev. 2009 Sep;19(3):365-84. doi: 10.1007/s11065-009-9109-y. Review.

8.

Neurocognition in first-episode schizophrenia: a meta-analytic review.

Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ.

Neuropsychology. 2009 May;23(3):315-36. doi: 10.1037/a0014708. Review.

PMID:
19413446
9.

Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?

Vinogradov S, Fisher M, Holland C, Shelly W, Wolkowitz O, Mellon SH.

Biol Psychiatry. 2009 Sep 15;66(6):549-53. doi: 10.1016/j.biopsych.2009.02.017.

10.

Psychological and metabolic stress: a recipe for accelerated cellular aging?

Epel ES.

Hormones (Athens). 2009 Jan-Mar;8(1):7-22. Review.

11.

Physical and mental health-related quality of life among older people with schizophrenia.

Folsom DP, Depp C, Palmer BW, Mausbach BT, Golshan S, Fellows I, Cardenas V, Patterson TL, Kraemer HC, Jeste DV.

Schizophr Res. 2009 Mar;108(1-3):207-13. doi: 10.1016/j.schres.2008.12.008.

12.

Premorbid IQ in schizophrenia: a meta-analytic review.

Woodberry KA, Giuliano AJ, Seidman LJ.

Am J Psychiatry. 2008 May;165(5):579-87. doi: 10.1176/appi.ajp.2008.07081242.

PMID:
18413704
13.

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.

Ng F, Berk M, Dean O, Bush AI.

Int J Neuropsychopharmacol. 2008 Sep;11(6):851-76. doi: 10.1017/S1461145707008401. Review.

PMID:
18205981
14.

Is schizophrenia a syndrome of accelerated aging?

Kirkpatrick B, Messias E, Harvey PD, Fernandez-Egea E, Bowie CR.

Schizophr Bull. 2008 Nov;34(6):1024-32. Review.

15.

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.

Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E.

Biol Psychiatry. 2008 Apr 15;63(8):801-8.

PMID:
18005941
16.

A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?

Saha S, Chant D, McGrath J.

Arch Gen Psychiatry. 2007 Oct;64(10):1123-31. Review.

PMID:
17909124
17.

Inflammation and schizophrenia.

Fan X, Goff DC, Henderson DC.

Expert Rev Neurother. 2007 Jul;7(7):789-96. Review.

PMID:
17610386
18.

DNA damage responses in neural cells: Focus on the telomere.

Zhang P, Dilley C, Mattson MP.

Neuroscience. 2007 Apr 14;145(4):1439-48. Review.

19.

Cognitive development in schizophrenia: follow-back from the first episode.

Bilder RM, Reiter G, Bates J, Lencz T, Szeszko P, Goldman RS, Robinson D, Lieberman JA, Kane JM.

J Clin Exp Neuropsychol. 2006 Feb;28(2):270-82.

20.

Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments.

Reine G, Simeoni MC, Auquier P, Loundou A, Aghababian V, Lancon C.

Eur Psychiatry. 2005 Nov;20(7):510-9.

PMID:
16139488
Items per page

Supplemental Content

Support Center